| HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity K Ulbrich, T Etrych, P Chytil, M Jelınková, B Řı́hová Journal of Controlled Release 87 (1-3), 33-47, 2003 | 258 | 2003 |
| Experimental study on the application of phase change material in the dynamic cycling of battery pack system J Yan, K Li, H Chen, Q Wang, J Sun Energy Conversion and Management 128, 12-19, 2016 | 251* | 2016 |
| Biodegradable star HPMA polymer–drug conjugates: Biodegradability, distribution and anti-tumor efficacy T Etrych, L Kovář, J Strohalm, P Chytil, B Říhová, K Ulbrich Journal of controlled release 154 (3), 241-248, 2011 | 200 | 2011 |
| New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting P Chytil, T Etrych, Č Koňák, M Šírová, T Mrkvan, J Bouček, B Říhová, ... Journal of Controlled Release 127 (2), 121-130, 2008 | 167 | 2008 |
| Synthesis of HPMA copolymers containing doxorubicin bound via a hydrazone linkage. Effect of spacer on drug release and in vitro cytotoxicity T Etrych, P Chytil, M Jelínková, B Říhová, K Ulbrich Macromolecular bioscience 2 (1), 43-52, 2002 | 167 | 2002 |
| Antibody-targeted polymer–doxorubicin conjugates with pH-controlled activation K Ulbrich, T Etrych, P Chytil, M Jelínková, B Říhová Journal of drug targeting 12 (8), 477-489, 2004 | 155 | 2004 |
| N-(2-Hydroxypropyl) methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT … P Chytil, T Etrych, J Kříž, V Šubr, K Ulbrich European journal of pharmaceutical sciences 41 (3-4), 473-482, 2010 | 142 | 2010 |
| Fluorescence optical imaging in anticancer drug delivery T Etrych, H Lucas, O Janoušková, P Chytil, T Mueller, K Mäder Journal of Controlled Release 226, 168-181, 2016 | 140 | 2016 |
| N‐(2‐hydroxypropyl)methacrylamide‐based polymer conjugates with pH‐controlled activation of doxorubicin. I. New synthesis, physicochemical characterization … T Etrych, T Mrkvan, P Chytil, Č Koňák, B Říhová, K Ulbrich Journal of applied polymer science 109 (5), 3050-3061, 2008 | 122 | 2008 |
| Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting T Etrych, P Chytil, T Mrkvan, M Šírová, B Říhová, K Ulbrich Journal of Controlled Release 132 (3), 184-192, 2008 | 118 | 2008 |
| Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting T Etrych, J Strohalm, P Chytil, P Černoch, L Starovoytova, M Pechar, ... European journal of pharmaceutical sciences 42 (5), 527-539, 2011 | 114 | 2011 |
| Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification P Chytil, T Etrych, Č Koňák, M Šírová, T Mrkvan, B Říhová, K Ulbrich Journal of controlled release 115 (1), 26-36, 2006 | 111 | 2006 |
| Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity T Mrkvan, M Sirova, T Etrych, P Chytil, J Strohalm, D Plocova, K Ulbrich, ... Journal of controlled release 110 (1), 119-129, 2005 | 85 | 2005 |
| HPMA copolymer–drug conjugates with controlled tumor‐specific drug release P Chytil, E Koziolová, T Etrych, K Ulbrich Macromolecular bioscience 18 (1), 1700209, 2018 | 80 | 2018 |
| HPMA copolymer-conjugated pirarubicin in multimodal treatment of a patient with stage IV prostate cancer and extensive lung and bone metastases H Dozono, S Yanazume, H Nakamura, T Etrych, P Chytil, K Ulbrich, ... Targeted oncology 11, 101-106, 2016 | 80 | 2016 |
| Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester E Jäger, A Jäger, P Chytil, T Etrych, B Říhová, FC Giacomelli, P Štěpánek, ... Journal of controlled release 165 (2), 153-161, 2013 | 75 | 2013 |
| Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model M Sirova, T Mrkvan, T Etrych, P Chytil, P Rossmann, M Ibrahimova, ... Pharmaceutical research 27, 200-208, 2010 | 68 | 2010 |
| Macromolecular HPMA-based nanoparticles with cholesterol for solid-tumor targeting: detailed study of the inner structure of a highly efficient drug delivery system SK Filippov, P Chytil, PV Konarev, M Dyakonova, CM Papadakis, ... Biomacromolecules 13 (8), 2594-2604, 2012 | 60 | 2012 |
| HPMA copolymer-based nanomedicines in controlled drug delivery P Chytil, L Kostka, T Etrych Journal of Personalized Medicine 11 (2), 115, 2021 | 50 | 2021 |
| Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release II: Impact of release rate on biodistribution P Chytil, S Hoffmann, L Schindler, L Kostka, K Ulbrich, H Caysa, T Mueller, ... Journal of controlled release 172 (2), 504-512, 2013 | 50 | 2013 |
